ArticleCancer management and research2020

LncRNA-ATB Promotes Cisplatin Resistance in Lung Adenocarcinoma Cells by Targeting the miR-200a/β-Catenin Pathway.

Weiwei Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.